Free CBIC CIC Practice Exam with Questions & Answers | Set: 6

The CBIC Certified Infection Control Exam Study Guide (6th edition) states that cytomegalovirus (CMV) is a common virus transmitted through direct contact with body fluids, including saliva, urine, blood, and respiratory secretions. In healthcare settings, Standard Precautions are sufficient to prevent CMV transmission, even for pregnant healthcare personnel.

Importantly, routine reassignment, work restriction, or removal from patient care is not recommended for pregnant HCP caring for patients with CMV, including those in the first trimester. The Study Guide emphasizes that the most effective preventive measure is strict adherence to Standard Precautions, particularly hand hygiene and appropriate use of personal protective equipment when contact with body fluids is anticipated. These measures have been shown to significantly reduce the risk of CMV acquisition.

Option A is incorrect because there is no indication for immediate post-exposure evaluation in the absence of a recognized exposure such as a needlestick or mucous membrane contact. Option B is not supported by evidence or guidelines and may contribute to unnecessary workforce restrictions. Option D is insufficient and misleading, as CMV is not transmitted via the airborne route and masking alone does not address the primary transmission risks.

For CIC® exam preparation, it is critical to recognize that education and reinforcement of Standard Precautions—not work exclusion—are the cornerstone of CMV prevention for pregnant healthcare workers.

The scenario involves an infection preventionist (IP) assisting pharmacists in addressing medication contamination at the hospital’s compounding pharmacy, with a focus on the medication recall process. The IP’s role is to apply infection control expertise to mitigate risks, guided by the Certification Board of Infection Control and Epidemiology (CBIC) principles and best practices. The recall process requires a systematic approach to identify, contain, and resolve the issue, and the “first” or most critical step must be determined. Let’s evaluate each option:

A. Have laboratory culture all medication: Culturing all medication to confirm contamination is a valuable step to identify affected batches and guide the recall. However, this is a resource-intensive process that depends on first understanding the scope and source of the problem. Without identifying the potential source of contamination, culturing all medication could be inefficient and delay the recall. This step is important but secondary to initial investigation.

B. Inspect for safe injection practices: Inspecting for safe injection practices (e.g., single-use vials, proper hand hygiene, sterile technique) is a critical infection control measure, especially in compounding pharmacies where contamination often arises from procedural errors (e.g., reuse of syringes, improper cleaning). While this is a proactive step to prevent future contamination, it addresses ongoing practices rather than the immediate recall process for the current contamination event. It is a complementary action but not the first priority.

C. Identify the potential source of contamination: Identifying the potential source of contamination is the foundational step in the recall process. This involves investigating the compounding environment (e.g., water quality, equipment, personnel practices), raw materials, and production processes to pinpoint where the contamination occurred (e.g., bacterial ingress, cross-contamination). The CBIC emphasizes root cause analysis as a key infection prevention strategy, enabling targeted recalls, corrective actions, and prevention of recurrence. This step is essential before culturing, inspecting, or notifying patients, making it the IP’s primary responsibility in this context.

D. Inform all discharged patients of potential medication contamination: Notifying patients is a critical step to ensure public safety and allow for medical follow-up if they received contaminated medication. However, this action requires prior identification of the contaminated batches and their distribution, which depends on determining the source and confirming the extent of the issue. Premature notification without evidence could cause unnecessary alarm and is not the first step in the recall process.

The best answer is C, as identifying the potential source of contamination is the initial and most critical step in the medication recall process. This allows the IP to collaborate with pharmacists to trace the contamination, define the affected products, and guide subsequent actions (e.g., culturing, inspections, notifications). This aligns with CBIC’s focus on systematic investigation and risk mitigation in healthcare-associated infection events.

CBIC Infection Prevention and Control (IPC) Core Competency Model (updated 2023), Domain III: Prevention and Control of Infectious Diseases, which includes identifying sources of contamination in healthcare settings.

CBIC Examination Content Outline, Domain V: Management and Communication, which emphasizes root cause analysis during outbreak investigations.

CDC Guidelines for Safe Medication Compounding (2022), which recommend identifying contamination sources as the first step in a recall process.

Surgical wounds are classified by the Centers for Disease Control and Prevention (CDC) into four classes based on the degree of contamination and the likelihood of postoperative infection. This classification system, detailed in the CDC’s Guidelines for Prevention of Surgical Site Infections (1999), is a cornerstone of infection prevention and control, aligning with the Certification Board of Infection Control and Epidemiology (CBIC) standards in the "Prevention and Control of Infectious Diseases" domain. The classes are as follows:

Class I (Clean): Uninfected operative wounds with no inflammation, typically closed primarily, and not involving the respiratory, alimentary, genital, or urinary tracts.

Class II (Clean-Contaminated): Operative wounds with controlled entry into a sterile or minimally contaminated tract (e.g., biliary or gastrointestinal), with no significant spillage or infection present.

Class III (Contaminated): Open, fresh wounds with significant spillage (e.g., from a perforated viscus) or major breaks in sterile technique.

Class IV (Dirty-Infected): Old traumatic wounds with retained devitalized tissue or existing clinical infection.

Option A, "Incisions in which acute, nonpurulent inflammation are seen," aligns with a Class II surgical wound. The presence of acute, nonpurulent inflammation suggests a controlled inflammatory response without overt infection, which can occur in clean-contaminated cases where a sterile tract (e.g., during elective gastrointestinal surgery) is entered under controlled conditions. The CDC defines Class II wounds as those involving minor contamination without significant spillage or infection, and nonpurulent inflammation fits this category, often seen in early postoperative monitoring.

Option B, "Incisional wounds following nonpenetrating (blunt) trauma," does not fit the Class II definition. These wounds are typically classified based on the trauma context and are more likely to be considered contaminated (Class III) or dirty (Class IV) if there is tissue damage or delayed treatment, rather than clean-contaminated. Option C, "Incisions involving the biliary tract, appendix, vagina, and oropharynx," describes anatomical sites that, when surgically accessed, often fall into Class II if the procedure is elective and controlled (e.g., cholecystectomy), but the phrasing suggests a general category rather than a specific wound state with inflammation, making it less precise for Class II. Option D, "Old traumatic wounds with retained devitalized tissue," clearly corresponds to Class IV (dirty-infected) due to the presence of necrotic tissue and potential existing infection, which is inconsistent with Class II.

The CBIC Practice Analysis (2022) emphasizes the importance of accurate wound classification for implementing appropriate infection prevention measures, such as antibiotic prophylaxis or sterile technique adjustments. The CDC guidelines further specify that Class II wounds may require tailored interventions based on the observed inflammatory response, supporting Option A as the correct answer. Note that the phrasing in Option A contains a minor grammatical error ("inflammation are seen" should be "inflammation is seen"), but this does not alter the clinical intent or classification.

The optimal specimen for identifying the etiologic agent in a prosthetic joint infection (PJI) is a joint aspirate (synovial fluid). This is because:

It provides direct access to the infected site without contamination from external sources.

It allows for accurate microbiologic culture, Gram stain, and leukocyte count analysis.

Why the Other Options Are Incorrect?

A. Blood – Blood cultures may help detect hematogenous spread but are not the best sample for identifying localized prosthetic joint infections.

B. Wound drainage – Wound cultures often contain contaminants from surrounding skin flora and do not accurately reflect joint space infection.

D. Sinus tract tissue – Cultures from sinus tracts often represent colonization rather than the primary infecting organism.

CBIC Infection Control Reference

APIC guidelines confirm that joint aspirate is the most reliable specimen for diagnosing prosthetic joint infections​.

The CBIC Certified Infection Control Exam Study Guide (6th edition) emphasizes that Aspergillus infections associated with healthcare settings are most commonly environmentally acquired, particularly during construction, renovation, or demolition activities. Aspergillus fumigatus is an airborne mold, and transmission occurs through inhalation of spores, not via person-to-person contact.

In this scenario, the infection preventionist should focus on air handling systems and environmental controls, which makes options A, B, and D critical questions. Ensuring that ventilation filters are appropriately maintained (Option A) and evaluating the proximity of air-intake units to construction activities (Option B) are essential elements of an Infection Control Risk Assessment (ICRA). Asking whether Aspergillus was present before construction (Option D) helps determine whether this represents a construction-associated cluster rather than baseline colonization.

Option C is the least relevant because healthcare personnel do not transmit Aspergillus between patients. Unlike organisms spread via contact or droplets, Aspergillus spores are ubiquitous in dust and air and are introduced through environmental disruption. Therefore, evaluating shared staff assignments does not contribute meaningfully to identifying the source of exposure.

For CIC® exam preparation, it is critical to remember that construction-associated aspergillosis investigations focus on air quality, ventilation, and environmental controls—not staff transmission pathways.

The correct answer is C, "Reviewing principles of adult learning," as this activity will best prepare a newly hired infection preventionist to present information at the facility’s orientation program. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, effective education delivery, especially for healthcare professionals during orientation, relies on understanding adult learning principles (e.g., andragogy), which emphasize learner-centered approaches, relevance to practice, and active participation. Reviewing these principles equips the infection preventionist (IP) to design and deliver content that addresses the specific needs, experiences, and motivations of the audience—such as new staff learning infection control protocols—enhancing engagement and retention (CBIC Practice Analysis, 2022, Domain IV: Education and Research, Competency 4.1 - Develop and implement educational programs). This preparation ensures the presentation is tailored, impactful, and aligned with the goal of promoting infection prevention behaviors.

Option A (observing other departments’ orientation presentations) can provide insights into presentation styles or facility norms, but it is less focused on the IP’s specific educational role and may not address the unique content of infection prevention. Option B (meeting with the facility’s leadership) is valuable for understanding organizational priorities and gaining support, but it is more about collaboration and context-setting rather than direct preparation for presenting educational material. Option D (administering tuberculin skin tests to orientees) is a clinical task related to TB screening, not a preparatory activity for designing or delivering an educational presentation.

The focus on reviewing adult learning principles aligns with CBIC’s emphasis on evidence-based education strategies to improve infection control practices among healthcare personnel (CBIC Practice Analysis, 2022, Domain IV: Education and Research, Competency 4.2 - Evaluate the effectiveness of educational programs). This approach enables the IP to effectively communicate critical information, such as hand hygiene or isolation protocols, during the orientation program.

The CBIC Certified Infection Control Exam Study Guide (6th edition) emphasizes that the primary purpose of construction barriers within an Infection Control Risk Assessment (ICRA) is to prevent the dissemination of dust and potentially infectious microorganisms generated during construction, renovation, or maintenance activities. Construction activities can aerosolize fungal spores (such as Aspergillus), bacteria, and other particulate matter that pose a significant risk to immunocompromised patients and other vulnerable populations.

Barriers must therefore be designed and maintained to effectively contain dust and microorganisms at the source, preventing their migration into occupied patient care areas. This containment function is the cornerstone of infection prevention during construction and directly aligns with ICRA goals of risk reduction and patient safety.

While the other options describe supportive or secondary considerations, they are not the most critical factor. Withstanding HVAC airflow (Option A) is important, but it serves the larger goal of containment. Sealing air intakes and exhausts (Option B) is a specific engineering control that may be used as part of containment strategies but does not define the primary purpose of barriers. Walk-off mats (Option D) are useful adjunctive controls but are insufficient alone to prevent airborne transmission of contaminants.

For CIC® exam preparation, it is essential to recognize that containment of dust and infectious agents is the defining function of construction barriers within an ICRA, and all other measures support this central objective.

==========

The CBIC Certified Infection Control Exam Study Guide (6th edition) clearly states that steam sterilization (moist heat sterilization) must be validated using biological indicators containing Geobacillus stearothermophilus spores. This organism is selected because its spores are highly resistant to moist heat, making them an ideal challenge organism for assessing the effectiveness of steam sterilization processes.

Biological indicators are used to confirm that sterilization conditions—such as temperature, pressure, and exposure time—are sufficient to achieve microbial inactivation. Geobacillus stearothermophilus thrives at high temperatures and demonstrates strong resistance to steam, so if these spores are destroyed, it provides high confidence that other less-resistant microorganisms, including bacteria, viruses, and fungi, have also been eliminated.

The other options are incorrect for steam sterilization validation. Staphylococcus aureus is a vegetative bacterium and is far less resistant than bacterial spores. Bacillus anthracis is not used as a biological indicator due to safety concerns and lack of standardization. Bacillus atrophaeus is used as the biological indicator for dry heat and ethylene oxide sterilization, not steam.

Understanding which biological indicators correspond to specific sterilization modalities is a high-yield topic on the CIC® exam and is essential for ensuring compliance with evidence-based sterilization and disinfection standards.

=======

The human immunodeficiency virus (HIV) and Hepatitis B virus (HBV) are both bloodborne pathogens that pose significant risks in healthcare settings, and understanding their similarities is crucial for infection prevention and control. The Certification Board of Infection Control and Epidemiology (CBIC) emphasizes the importance of recognizing transmission modes and implementing appropriate precautions in the "Prevention and Control of Infectious Diseases" domain, aligning with guidelines from the Centers for Disease Control and Prevention (CDC). Comparing these viruses involves evaluating their epidemiology, transmission routes, and occupational risks.

Option C, "Transmission may occur from asymptomatic carriers," is the correct answer. Both HIV and HBV can be transmitted by individuals who are infected but show no symptoms, making asymptomatic carriage a significant similarity. For HBV, chronic carriers (estimated at 257 million globally per WHO, 2019) can transmit the virus through blood, semen, or other bodily fluids without overt signs of disease. Similarly, HIV-infected individuals can remain asymptomatic for years during the latent phase, yet still transmit the virus through sexual contact, blood exposure, or perinatal transmission. The CDC’s "Guidelines for Prevention of Transmission of HIV and HBV to Healthcare Workers" (1987, updated 2011) and "Epidemiology and Prevention of Viral Hepatitis" (2018) highlight this shared characteristic, underscoring the need for universal precautions regardless of symptom status.

Option A, "The primary mechanism of transmission for both is maternal-fetal," is incorrect. While maternal-fetal transmission (perinatal transmission) is a significant route for both HIV and HBV—occurring in 5-10% of cases without intervention for HBV and 15-45% for HIV without antiretroviral therapy—it is not the primary mechanism. For HBV, the primary mode is horizontal transmission through unprotected sexual contact or percutaneous exposure (e.g., needlesticks), accounting for the majority of cases. For HIV, sexual transmission and intravenous drug use are the leading modes globally, with maternal-fetal transmission being a smaller proportion despite its importance. Option B, "Needlestick exposure leads to a high frequency of healthcare worker infection," is partially true but not a precise similarity. Needlestick exposures carry a high risk for HBV (transmission risk ~30% if the source is HBeAg-positive) and a lower risk for HIV (~0.3%), but the frequency of infection among healthcare workers is significantly higher for HBV due to its greater infectivity and stability outside the host. This makes the statement more characteristic of HBV than a shared trait. Option D, "The risk of infection from mucous membrane exposure is the same," is false. The risk of HIV transmission via mucous membrane exposure (e.g., splash to eyes or mouth) is approximately 0.09%, while for HBV it is higher (up to 1-2% depending on viral load and exposure type), reflecting HBV’s greater infectivity.

The CBIC Practice Analysis (2022) and CDC guidelines emphasize the role of asymptomatic transmission in shaping infection control strategies, such as routine testing and post-exposure prophylaxis. This shared feature of HIV and HBV justifies Option C as the most accurate similarity.

Benchmarking compares infection rates across healthcare facilities. For accurate benchmarking, case definitions must be standardized and adjusted for patient demographics, severity of illness, and other risk factors.

Why the Other Options Are Incorrect?

A. Data collectors are trained on how to collect data – Training is necessary, but it does not directly ensure comparability between facilities.

B. Collecting data on a small population – A larger sample size increases accuracy and reliability in benchmarking.

C. Denominator rates selected based on an organizational risk assessment – Risk assessment is important, but standardized case definitions are critical for comparison.

CBIC Infection Control Reference

According to APIC, accurate benchmarking relies on using standardized case definitions that account for differences in patient populations​.